The New York Times publishes first article in a series: “The Middlemen: The Opaque Industry Secretly Inflating Prices for Prescription Drugs; Pharmacy benefit managers are driving up drug costs for millions of people, employers, and the government.”
PBMs represent a “staggering national problem.”
Urges Congress: no further delays in enacting bipartisan reforms to reduce Americans’ drug costs and to protect access to pharmacies and prescribed medications.
H. 233 includes important reforms that will help curb PBM tactics threatening Vermont patients and the pharmacies on which they rely.
Responds to RFI from Department of Justice, Department of Health and Human Services, and Federal Trade Commission.
The Massachusetts advertising campaign comes as part of NACDS’ broader advocacy work in collaboration with in-state partners.
NACDS participated on May 30 in a panel discussion hosted by thINc360 – The Healthcare Innovation Congress, which focused on how pharmacies and other healthcare stakeholders can help broaden the impact of food is medicine programs through technology, partnerships, and evidence-based interventions.
NACDS is calling attention to a new policy paper published by the Global Healthy Living Foundation and authored by Robert Popovian, PharmD, MS, Founder, Conquest Advisors, and GHLF’s Chief Science Policy Officer.
NACDS is reminding lawmakers that pharmacies and pharmacists have an important role to play when it comes to driving food is medicine initiatives, providing prevention and management services for chronic disease, and delivering total health and wellness solutions.
NACDS President and CEO Steven C. Anderson relayed recommendations in a statement for the record of the U.S. Senate Finance Committee’s hearing today on “Rural Healthcare: Supporting Lives and Improving Communities.”
